Additional Metadata
Keywords CAR T cells, CTLA4, dendritic cells, immunotherapy, M2 macrophages, mesothelioma, PD-1/PD-L1, tumor micro-environment
Persistent URL dx.doi.org/10.2217/fon-2017-0234, hdl.handle.net/1765/108710
Journal Future Oncology
Citation
Dumoulin, D.W. (Daphne W), Aerts, J.G.J.V, & Cornelissen, R. (2017). Is immunotherapy a viable option in treating mesothelioma?. Future Oncology (Vol. 13, pp. 1747–1750). doi:10.2217/fon-2017-0234